FindTrial
Sign In

An in-depth investigation and analysis were conducted on the real-world effectiveness of the Adaptixââ??¢ Interbody Cage System at a specialized spine center providing tertiary care.

A Exploratory Study and Analysis of Real Word Evidence of Adaptixââ??¢ Interbody Cage System at a Tertiary Care Spine Centre. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061495
Enrollment
100
Registered
2024-01-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M431- Spondylolisthesis

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Stavya Spine Hospital and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the cases who undergoing inter-body fusion with Adaptixââ??¢ inter-body system. cases giving consent for surgery. age group 18 and above

Exclusion criteria

Exclusion criteria: patients who are not willing to be a part of study. Age below 18.

Design outcomes

Primary

MeasureTime frame
To assess the safety and performance of Adaptixââ??¢ through retrospective review of cases Done at our institute. To identify residual risk for Adaptixââ??¢. Identify off possible label use. Identify previously unknown side effects and complications. Timepoint: Visits at 3 months,6 months and 12 months—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDr Mirant B Dave

Stavya Spine Hospital And Research Institute

mirantdave172@gmail.com9099597234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026